Liquidia Corp - 8-K Filing
FDA grants Fast Track Designation to YUTREPIA for Raynaud’s phenomenon associated with systemic sclerosis (Items: 8.01 Other Events)
Tickers: $LQDA
FDA grants Fast Track Designation to YUTREPIA for Raynaud’s phenomenon associated with systemic sclerosis (Items: 8.01 Other Events)
Tickers: $LQDA